INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139547, 6534, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171488, 1768171488, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139548, 6548, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171490, 1768171490, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139549, 6551, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171493, 1768171493, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139550, 6559, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171495, 1768171495, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139551, 6595, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171498, 1768171498, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139552, 6597, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171500, 1768171500, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139553, 6598, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171503, 1768171503, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139554, 6599, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768171505, 1768171505, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139555, 6604, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768171507, 1768171507, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139556, 6621, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768171510, 1768171510, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139557, 6630, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171512, 1768171512, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139558, 6630, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171514, 1768171514, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139559, 6634, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171517, 1768171517, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139560, 6637, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'789c6553bd6edc300c7e156e5d8c038202dd3374ccd46e41069e449f09c8922b5297aa4f9367c993f5937d4d8beb60c096a98fdf0ff968f4aabed0cab953aced62542aad1235b06bc93611a3220a71addca9ccc4f12ad584649e25b8911ab15909ca2ef1400b8c7f9a859ac989be2ff24ff9956ba7b99695564d91bc900900d120c78934939555806082de81339d8566764e1345d92447cd172a997c118a05c0012c1b180f003c80887ad5d8387d32606753c7b7f7d16abf04953b295a8b39a8c88f26d953a72a5ba943c4bd4406bdd23c4152049f545e4ff484524e03170634433b20fc6f448dca6198b7745f56e58996be151fb44a9e68ede5a849e03d730dbe1f4b42df5a5277f055f356cf9cc3706417699bd63d9e133d3f3cbcd0f3e72f2ff434ec7cbc31ff7a63be1fdecb41881f09690ea98d78f34f15ef134c304f6296f14c346bbc88c3f2110d92c943c1cc61109e53b3e5f62b544162915ad5cc8706ad559dcf3a3c82d0662109396c09988731655e652d7568baa0f0b8e41c967e38324a80219796b8d2225c9da05aa6f7b761c2850d0e6976f045cff4fe76343c6cf976ccd4bd1db7e37b43564cf61f236077a98a81b8315a106c0b375520bb590f4b31c5ab89fe6a754fe5235f7ca841e11ef5e059173ec7829c53c7a51328451d50635ea6bf398c494fc2fb428cd189955fe1b1f575f3b262cb663039ab63cec656550ce5b9b66d8c6d18d6dfd6603be41f2bf771d9fba6bf014c2d752a', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768171519, 1768171519, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139561, 6648, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c5590cb51c4400c445351005be4c0a73873e32cc6b2ad622cb924cd2ebe9103096c2c84422468bc7cafa39e7edd7da32ff088262c9303ca000f46055bb08ac3b5c34af67ebebfbb06a3a955bcbc771daeabe911eb01622650a91bf84a85472e5054c29065e0b2ff80510d96b6b26961017678163d09cc5bda3b8973f091634b08960b2274f75de8c7232d383cbd97558524fc0a7aaef54f5e9652db40b06aa480b102d64a3665a41fe703d0467b83aa25156cc6815fa744aa51703f18fb33e808b7553d8c076e0b0c3c663faef4f1fa06e89e753068783f0f8c6633e101162ea64f9dadc7449b9e623e40934be3a515f5bcd138528924b204d977e913c79ce1eb46316f958460aa5bd1dcb8e7ed7bfc36eb938e4da60e32784a0bb2ffd48b5d739cb26f7492e191445b8e8869961f2097a74c810e1ebd49aa764e5f766a3c506521df613789c86628579fbc4ed5a1', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768171521, 1768171521, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139562, 6652, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768171523, 1768171523, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139563, 6654, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171526, 1768171526, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139564, 6655, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c7552cd6ed4400c7e153f4059099038706bd5822a71d8031248550f4ee2cd584dc661c69390b7e1597832ec4977bbdd8a5b7eecefd7f759349172148ec0195a899a9063c72d2a75605f2754a6a81916d600619d28658a999567d6155480d517c749a2cf5dd9523b948e630f3681a3615c03c60ea64499d26c78336d70f64b03414f03b438e532d00e1e3e3dc2c3c70f8f7023bfe107a6684019eecf852e98011dae8f18db155c6b2f69859fd0a5d243891da58a6c33334bc9f0e5f61af29a95c62ae53f5637448545468a208e219960090223aed090d9a4d3d80ebe074a040167b27fb69169b60f57d0495b0cc1618da6a768390cd071c686074bceed077a435881149fc8bb78f15b79aa8344bf0a5b8a35ca3671635d6cd11e4bb23a0c93cd68da0af31478ffedeef6eb9d6d499f70f4a113405d4fd4929572c17a5cb3b68b936a40059c0c654a6c991de58c95192d8991d48238883d9ad9c9cfc4aee01cf5997bb6957a37c5e2ed4af2b1539fd56fbe80df8e8a20525f0fe8ac7ea5ac5b0c67b963938d91624b5b8f54a9e4000d278ba5b62fc351ad2f2f81871affa5e6ddcb19fadcded2c2a22c31c3cd20e2b411fdfd33ec4f3dbc85811ca40ca66c16eea079b5f94c2eaf8baf74a6efef9ff7309ae00078f0622d5bd7cfb138878da3ba6b0b923c5f379b383fb95b1a9bb4cabbc33fda947625', X'789c65934d6edb301085af32073014ffc441b6018aa2dd054877411714391607a64896a4e4aaa7e9597ab23e4a9611230bfd8014df7bf3cde86554e254eb98be84ac3aa6af21f5999437f45612fbaed84cdf73c07b111fc49360d7f4e225174e6c2824e5dc440acba455cc83e3867e582693868e2cd65db8502b412d56e2a44cb30194ac7416879dc4102d76f47234aa22ec0bf43cf5eab7f4f2876723526d0e2916099ec2090a1f82b513157516df9114ba48b108d4b372cd7dfe6cc3e00cb55cbf66bf7e791a9ca3cea99cabf045a1382a81d418c41067c4031d049094a4a81aa0f9cce5061355cf71af403255e31b4f18ecb61bdad7ebb8a1039e073c2b93c72df55d432fc648f5a86837b51ea9a74e33f099742f3a050f2c66f5a0133a37b839da27bbe70ded9eae8e8fb89e17b7c3feea36b8b20e40e58fee16417c13327fe28c28658aa2e7b66f9b23241ecedd83d9d0c58ab675bf4bca0cf3be789d5865c404cc5db35d3fa6765e44d4b5d725384ecaeb3a3d8b3c158b953851e25f832450dc1dfffd85ce7e4b17e6f35c9901f2e93ee03a9e696151bba8adf0c8a4431f1d179e8b8f29b8e03ba430926b46f8f492f3dcdaf7a79ff4bec30dff0304c1272f9392a19320a03d6f6a756e3075e4b256180cbc54e592067fc6e618dcc83d8aabb43fa0b84b6b16ec28657f83d3aba90e6844cd3a49cb607bf7cfd563328aa9d9d1a2dcd05b642d27d1f47ac5f91ae27518327de3a8fe039977650b', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768171528, 1768171528, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139565, 6665, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'789cad53cd6e1331107e9579804d480a51256e11a852251095405c1007ef7ab23bc53fc163a7d9b7c9b3e4c998f1a6695aca8d4be4597bbebf99ac77869c691dc2c7c8a647b889c9339860e16b4e18fa3c307cc04d49714f1e81e4eedc42017626512c0c1b692bce648a811bb9e85cb1147a88c938c8fa3acbf75a71e12d0696974de5d9c6078b4911a4ef1ebb8a31876f035e7643f724c2ec3193fb4b0b9f05c70d5cad16e0fb4ab05ae8f102f1498120247c8ed2c5d061c869f2a250cbab95f4bf919f4f156f82aef504fa9a839a884ae4b2dd3a425bd322e35819b2a1a0f15c57a80696f315f4531cd77a54da4bc37c5971b454fc1cd6d60b0a9fa46a4bfe9798ce0468116c0c0848f22ca916b8fd2c81c0ed7748b16454c4e2f2e326bc98fa890c9358c90fd46996c7431e921ead0438366051729de61eaa18c61d26cae3a3380a9b49d11c7ebc7df7b3a677da8e6afec57804d0cb10d421428861d652c4df8576c6a14ca9016f7e299b40fb7acfa5e54cb9544c1561c09373d427e36739cece05b48649b6ec6e30690c3d65b128516461d32752be5771c743c22e7a2faec4b69d82793e1b693ceddadd1750bba32c0c0cb1a4faaf381e960b896714ae7527210b712721ca2288f8bd70093f3085c2ff91145ee5fc03d2be6914', X'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', NULL, X'789c65504b4e03310cbd8a0f005df40a5d7302d44548dc89c1638f6ca7309c1e07844688451459eff97d7cc1db30fda015a1b495843cac04a94091064d9d6401c18aee142526eb7578ac280124101d6141a312461536dd061fdb248deed4466187778a9eb81a184a61b80da993788227150ab5e9f3170272a8362a157e80ad58504d75e37d1a57a39c0bcf8939e1a08ce42951314d53acd3d2d16605f4ef38ca2de75fe6092e9c75535d1cbcebe006195461fdc9039b6974d3f565d69cf7c9bfc4a391bf1d765397e99eba289ffb9a4ec9fad7bbe35ca8d0763f7a3f9faff9ced72f0ba09156', X'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', X'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', NULL, 'NCBI', 1768171531, 1768171531, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139566, 6666, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'789c65504b4e03310cbd8a0f005df40a5d7302d44548dc89c1638f6ca7309c1e07844688451459eff97d7cc1db30fda015a1b495843cac04a94091064d9d6401c18aee142526eb7578ac280124101d6141a312461536dd061fdb248deed4466187778a9eb81a184a61b80da993788227150ab5e9f3170272a8362a157e80ad58504d75e37d1a57a39c0bcf8939e1a08ce42951314d53acd3d2d16605f4ef38ca2de75fe6092e9c75535d1cbcebe006195461fdc9039b6974d3f565d69cf7c9bfc4a391bf1d765397e99eba289ffb9a4ec9fad7bbe35ca8d0763f7a3f9faff9ced72f0ba09156', X'789c5d934b6edc300c86afc25d13c033c0f49dee12a028ba690324bbc12c6889b6894aa221c9697dad1ea4672a258fe7918d6dc97c7cfcf5eb014da6c8e8c09073f01b9d4b809120e548a1cf0305b2d0ce60a2a4b4711c7e71e861a431b395decd06034c8173823c4499fa41df045a952580741a19d8b0d3c44dcbc1d6e428993824b8797c784cb70da4910c776cb4f9fcaa748e18d2b28589b6b0dfbd3fc0b376b80e7338535c0a9b8a42e779a08be2c1cd89d316ee753a6897a18dd674803d85dc68783745f9c39ea0706a0d8182072f8cf0efefc6690e7a883a8096791e38c13a0f87815b3eb6bd045e3488afb4e35003af0738d3a639e86f852deaa5299912d73a5aa91559628f81935790fddb836af2e100f72e0f557e857e07bcc08c913dc61932c69e7229781eb301ce505aa34bb2ce50b2618780c12e9f6d91fc63e9f1e9b04c7d8c3c1e6fe9b282bd516d5b769ce7225e27d1abd6dd14aa172e1d068e7051d812e6e1e41c495e329bf5acf6bbcf0778ba50e0e73a377c8be837a324e57851b7519456f356902fc521e90ca6ccc64d96e009708a342568f49346b6143d5b5ed663a0c94bd0f0465bdf1daa08ba3d8b3a8494e787646cdd7ce515cd2d7f63b52e07ea3a356065ea512d9ec18b3ef4329555114ccda6b4468c61b8a1be81afa70de5ea90f41668d1db2d7cd7a3b1b62add549d3d59bd2355792b942048865343773a654f7958af5c2c46ca1832fc07c1626b5c', X'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', NULL, 'NCBI', 1768171534, 1768171534, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139567, 6684, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171536, 1768171536, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139568, 6694, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171539, 1768171539, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139569, 6708, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c5d93418ed4301045af524b909a96d8009add0c428805d288e10215a79294b05dc165774f761c82137212be93162076891d7fd7ffffe53ed6c5dabcd0fb872752a7b568e2a271a3c4996719a92e65ffa008bbb7c23908711ee9a2ae96b1bcf0a0512b57bc9e685db8240e166dd680c35278ed621b5908dc8f7084fa2038f9bd69c10d93151ad56b1177cd33e17595e258915c69c1f72d68def5fd4c0f12b8b990b7b0509251c3b1431c2a61a0804385236569c5f0943d69ad024daecb95373f51889a3528b62835afb053f18a7d3951b2acd5ca69f7786440abf54914a2d59ef16555f17d9fc70b061592699250fdd78f9fe2ab40b95bd44c16478114a26ac7525a79b7cc638bd5e9ba187111b20917f4e11396758df2afb1337d942cddd263d11cfab6d353e55229da759f6336723cdfd1270caff041b88e56dfc282086c451308754f2419ae6638dc682c6d868fda5bea5282280e277a111acd8fa2ab2245482276ccd33c6e677a424f515e211c34c4eb5a8cc37247f717d31171c5ed86c17628403f580e86269035f5fa6c229791fb55de87db3b580ccd48013970fd28450d2900948b0acc7de904821118b95103d1aab9ed941ea0090ad9e80d8aa2777415f906a10f630bdd000a56cc7b541790fbacbd3e1ab68e5f68077d7d5879468b15b203929fb48299bf0cfc57fa418a7041bfae339882b51b271bbd7011faca032a7dfd965e9ee9f3c1d73efe84963a8e36f7da90f9105b3734dfe893ca031209fbdfd1cad0ff3da713b041543b38c94a8f3681da3fbc1d70fd757bd5da7fefdf469575a8', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171542, 1768171542, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139570, 6725, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171544, 1768171544, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139571, 6738, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171546, 1768171546, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139572, 6741, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768171549, 1768171549, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139573, 6761, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171551, 1768171551, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139574, 6775, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768171553, 1768171553, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139575, 6781, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171556, 1768171556, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139576, 6799, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171558, 1768171558, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139577, 6799, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171560, 1768171560, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139578, 6800, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171563, 1768171563, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139579, 6815, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171566, 1768171566, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139580, 6820, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171568, 1768171568, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139581, 6826, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171571, 1768171571, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139582, 6827, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768171573, 1768171573, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139583, 6828, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'789c6553bd6edc300c7e156e5d8c038202dd3374ccd46e41069e449f09c8922b5297aa4f9367c993f5937d4d8beb60c096a98fdf0ff968f4aabed0cab953aced62542aad1235b06bc93611a3220a71addca9ccc4f12ad584649e25b8911ab15909ca2ef1400b8c7f9a859ac989be2ff24ff9956ba7b99695564d91bc900900d120c78934939555806082de81339d8566764e1345d92447cd172a997c118a05c0012c1b180f003c80887ad5d8387d32606753c7b7f7d16abf04953b295a8b39a8c88f26d953a72a5ba943c4bd4406bdd23c4152049f545e4ff484524e03170634433b20fc6f448dca6198b7745f56e58996be151fb44a9e68ede5a849e03d730dbe1f4b42df5a5277f055f356cf9cc3706417699bd63d9e133d3f3cbcd0f3e72f2ff434ec7cbc31ff7a63be1fdecb41881f09690ea98d78f34f15ef134c304f6296f14c346bbc88c3f2110d92c943c1cc61109e53b3e5f62b544162915ad5cc8706ad559dcf3a3c82d0662109396c09988731655e652d7568baa0f0b8e41c967e38324a80219796b8d2225c9da05aa6f7b761c2850d0e6976f045cff4fe76343c6cf976ccd4bd1db7e37b43564cf61f236077a98a81b8315a106c0b375520bb590f4b31c5ab89fe6a754fe5235f7ca841e11ef5e059173ec7829c53c7a51328451d50635ea6bf398c494fc2fb428cd189955fe1b1f575f3b262cb663039ab63cec656550ce5b9b66d8c6d18d6dfd6603be41f2bf771d9fba6bf014c2d752a', NULL, X'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', X'789c6d53cbae13310cfd15ef00a9ad544082ed70592236b04377e1493c1deb66e251e2b41dbe866fe1cb70d2767a85ba9947727c7c7c6c3fe13010477a93614e3c615a60223762e43c810c804e5922703c4a385206d60c6421cede768e9ea2648b87448e66956490083a12f40939eee08bb11fa0171d6140dd02460f27544adb2ca1f481c0c9344ba4a81b7057354098392ce092e46c591b5f10f1dbc60a3da6c4941a1946c58344fe6d380c013e3e1005b9f4bacc8678dbed37d0bdc7fae8378da0fbf06e073f2dc38de95279cd69c03b079b4598945d09984c5ca26cba33d71a06bb77772b4ff842430991f2ead60e7eed3f3ddbe3f333740f5cc344104521f0c44a1e549a82a7ef3fa02f5aaffffe992da5f9641749ca6194a21767c42f3bf8ca46a6ff15b18aeff6b52f0e9367743095ec82b9617c25686bd96c82948f64dfa249667677e5dff8854e9c69f3c8da5709b3f264e6e8b5638982f591aa0e67876e948093c5666bb4444d6c85d5e1b8969a97ac3459de1b8dd830aeb336dc87a3366d28c962d28aad3cb7eaae152c0de8ccabebff0eba8b6147ccad8910e848e1d5d895e8291dc4f4d7a10c74362e1bd5cb12e42ab4099770a7501bdd8dc15c28be8af08fdab0a21fed8bb1ce4926d1264c3cd772ea6e99fad551a0e86d872830067014428bbb391cd9dc742067f626e634b21b57870c8367caff00907872a7', X'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', NULL, 'NCBI', 1768171575, 1768171575, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139584, 6844, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768171577, 1768171577, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139585, 6845, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'789c6d933d8edb400c85afc22e8ded20409022a90ca7c8022eb70b528c469444786628cc8fbdbacd9e654f96476917dec2850d8933241fbf473d4f4c8386a0374923454d5235dbe3ecb28b5c39177299a973857bd2441509c7d3e9ebf1cff14b213f69e0825b1a686cd27390c494d96b8c9c7a574553f949a7cc78c4c93c69c1ef2209f528f09543a132690b3d25add421599b5d0d0b4576a565ee7fd1a4375ccdbbb7d7f7188a57d2e1edd53faefc5e12e53c044017ca9024f2382c74933a91a319c369728134d3e0a2a0e52405f32f284da55a6124558c985df2bca33eb7716f7f1646d0aff38189ab889816f4364259cac58ac4456757a765673d5ae2973938a8ed29b6e20354e3cd8e6eec2e894b39d05930280d2dadb5a9822eecd859f9d07a73c6157803714cd00c68d05606882910e8824b46e3d1c9c5853b2857b768eaa96a05834e82e4d641cee60a8655a0325312b3dd329a1f96dc5d3ad0d34013634af1241103e5cd9c4c658973d50883db38da1c5736262dc18eb0d8286b9e567d112f15d4bd6f99fab62e20306637835c784884a25b4c51c78907a4bb70a0bfdf7efc03c0597a8085b847f4cebfcffbd30e468fd3be67ec06fa069975ce5a59d28e6a96312c9e33b6a67c26f479d73f18ddf74cbbba397b978fae52218cae82364610e9ae0b526cfbec8b5a0d196cfd5a05d6cfdfdfdad796db681ee81934d80de80e49d8d68d41d866cd3a48e047626cd361e97734ff0fd0cc7720', X'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', X'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', NULL, 'NCBI', 1768171579, 1768171579, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139586, 6849, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171582, 1768171582, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139587, 6861, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'789c6d93518e9c300c86afe2c756624733d5cebe57aa56aab44f6d2f601203514382123394dbec59f664fd032c65dabe0c43b07f7ffeed7cbeb1f35c7ba12f31732bf41c539f8983a5ef9a24b4da65fa16f378e3acac2e90c3d73d09ef5afee8926178c8234e1b688c1ed131e413fde8e43dc870a05a886def82cb2a492cc5c4decf154d4e3bbc2ccf382a44a2adcac1cd313105ceb10543728674ac65d5edc53ab314a29ee7a2adfc530271019a495d2f141b52845a7c2f9019eade96d03ca1729cc03075d16f8aef3d6c61216a093569ccdd024ba613a49ce86b4371902080d4439e894125683ed4917e5087641734bebd5e4885f31081fce14afdcbc7b75710f23078c93c1a59217734d7971e59c5cfbb3505c185f65486b59b99561bfeefd63de366d58abfd47300dec921157223296dccd07b3a3ff42fc8870aa6f6a06e18f031cf09189b71494c046bb02b07d6a4645a4b8f677459a630a18b542170f08c3e0bd1e04708e0709d0c665796872e57ca900b765b9fadd0c15356655326b2e0fddd6ea98615f0305ae9f244cfd864d351cb63fbefe214d2aeeccc612b2b606c03a8676a3ca60f800579d15f96f5d35d639baefba563ba233d2efb719adce08c06d8c1ebeca0b05e93bcdfbc3f37add85247546d31b4d26771ac4ee5f778dd3030e3472b74ade872aec0b87afb78fe0da7946951', X'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', NULL, X'789c6d933d8edb400c85afc22e8ded20409022a90ca7c8022eb70b528c469444786628cc8fbdbacd9e654f96476917dec2850d8933241fbf473d4f4c8386a0374923454d5235dbe3ecb28b5c39177299a973857bd2441509c7d3e9ebf1cff14b213f69e0825b1a686cd27390c494d96b8c9c7a574553f949a7cc78c4c93c69c1ef2209f528f09543a132690b3d25add421599b5d0d0b4576a565ee7fd1a4375ccdbbb7d7f7188a57d2e1edd53faefc5e12e53c044017ca9024f2382c74933a91a319c369728134d3e0a2a0e52405f32f284da55a6124558c985df2bca33eb7716f7f1646d0aff38189ab889816f4364259cac58ac4456757a765673d5ae2973938a8ed29b6e20354e3cd8e6eec2e894b39d05930280d2dadb5a9822eecd859f9d07a73c6157803714cd00c68d05606882910e8824b46e3d1c9c5853b2857b768eaa96a05834e82e4d641cee60a8655a0325312b3dd329a1f96dc5d3ad0d34013634af1241103e5cd9c4c658973d50883db38da1c5736262dc18eb0d8286b9e567d112f15d4bd6f99fab62e20306637835c784884a25b4c51c78907a4bb70a0bfdf7efc03c0597a8085b847f4cebfcffbd30e468fd3be67ec06fa069975ce5a59d28e6a96312c9e33b6a67c26f479d73f18ddf74cbbba397b978fae52218cae82364610e9ae0b526cfbec8b5a0d196cfd5a05d6cfdfdfdad796db681ee81934d80de80e49d8d68d41d866cd3a48e047626cd361e97734ff0fd0cc7720', X'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', X'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', NULL, 'NCBI', 1768171584, 1768171584, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139588, 6928, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'789c6d53c16eda4010fd953926922160a246cd8d828290905a45453d200e83bdf6aebade41b36ba8f307fd0b2efd113ea55fd2591b529270b0b49ed979f3deccdbb98374307c482068054fd33194b85390a1c3d29ac2d28b7180b0a15fb04776c695c9f1a04da9ad7c417edb3ae33256e8550e6cfc4fa002ac2a015d0e055100acb675c060c8f93e8c7dcc8febb2f6415aa783ffad357a6055d14e808236feb22da0f794190c92db9ba0df53945ee81a20c162a8546eb2aea1006188046d9d7fd0e5618b1c229f8caa8d716d49a4c3b86dfab04a076b98505549709cef147b0553ae4b785698b5e8c783d44ede80ce9433012d343290d8b850dd55398a1e215ea98eee9ee269950ed7b064e9cd0d0416dccb9a559aae61fe3add9acf1cdbc454e926e77360b486af1c34f938ea0c74b3a5a09cef92f797309926ab7c504c5616b553d6c3cd62bae84d6e3bc95163af153a7772eba41596d36fbdd2d659cde4c83756d83a5f485ec672b39c7dbf05e55e9a2ada21af3399d6e3f1302f64c4c128173c20cb026a66f9b1a2553844ee71b5301c0ca02a214723999c0430eee4c38675f4263a50b3a767f8fbfbcf27a95adc55c6dd0dfb0f23a82085445629a27371c1c99527931e0f828be515e44030baec6fa21d301758138774369c287c2fb07f2d9880af331dcdc5a610eb1b97c0562bd7043a1f6983bc892e498058ae0572b8339c005a2bbe607942ee02dabf224a6c38fedcce428ee997fb3efc10bcab7cdf884cba37f10f90116971', NULL, X'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', X'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', X'789c6d933d8edb400c46afc22e8dd740825c6091262982145b0629a8195a223c7f98a1ec28a7f1597cb27c23add7de20a5a419f27d8fd48b8ea911274f2f4b2c9663a37ca01f27a93e37a12f9c780c7a08f98f26cab7d7fdbce5dfead416729c4893abc2f8629350d576ec55a6a5e4312c4ea2329d2749c43e6ad26652c5d3596da28c0b95bcf220a68ea278756c9a53dbd3b70331153c49329ab8511300c8bbbabbde71a136e539781c0887a77b13709244a9a324b7d01866c7634e7454dbd3b3f7dafb70a0f690fc2d221285d9cbada79769f17525db9104715673580ce7e2c0819393b65bb538a01b0338e4330d21674fa54a6b73953d7def3a4184cf8f967bd007bb8aa4732be8217e476afd85abb353b05a06911cd1b6ab62006cca02b119ea82ef8661ecec217e937a5260a2b69b0836fba84ad6861bfd34f2904305a9fb3b9961aab6f2da527a9bb0ac09a177d5d5e65272353d09d6009a8057bb305cfdbfa46dea8730abc7c912d86d3a3a333f8ce45e3762af20aff5da71f5f736b03dfdfcf8e917f45d2f2e60e6308465f622b15b4b827e8debb25145f8a539f1d0721db07ebece23b2c4921300d634ee71db314efafc84bdaa34e1326487a5f5d1a068b7dcd7feb5eabb7bbd5b123c8e3a04a1001d01a45f85834d9b24612cdbebca6a2c6153b04540f898935aae9a461af04f79cae97a59a7b5fd0b1f1a887ab5eb05ab6633aa3fb77f20003ae938615ca56613bc297f018f4079f9', NULL, 'NCBI', 1768171586, 1768171586, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139589, 6933, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171589, 1768171589, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139590, 6945, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'789c75934d6edc300c85afc2650b18d3a468bb2f5014182059b5c8a6c88296699b807e0c8a9ec43d4dce929395925d67a6836e66649be27bdfa3f4f584ecb1f504df52c681e07b92900163f7faf24385e2a06386fbf4ccbd4fcfe8380267d0656287de2f805de0c85949a88324e5ddeb8bed2e55b8f7b65d5a166a25b50af29c278a995384de14678f6aebdc406f1a9ed51ee30079b1ce811d609b934ca5047494340fa3fd13743c50563e11a8a0d3031c238c845e47874290494b1bebcad10a4e14d39ce1ddf1e1fdee5baa6e75eb73326e4855a6810945d99931314cf30821d5962743b57e3db9eab81065d679f50f4f63f95c11af256252e809335b1487ab50078a5403ac7517c18a89952f0d68da926f8026ee6659d795cf596dbbbd30577f83a2a8a52fd893523ec04f0b6e120e288b317564083d74e42d4659496bb4320f803b8b4df4f8f0bfe9748592dbb97296524519a8d620b492b0039bb6539943d13a0b6ff368ceaa689bbae50077c908f9b7716fb466976c1c5bc4d6219c4717708196ce4e5b41287adc9b375a0a0210ca996e03edaa98e9e2f855e0abf44f8c5b78766cdd0898b781bccda0067e31040884d1d2fe757bfb683f1f1f2fe7bd5e875530f57dd5b1d779bf7246f9e9e606c25003fd5297ebecfeb93f0d3cb19aa97defdbd60f9f21dc35e56cb914fe00cdd572fc', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768171591, 1768171591, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139591, 6969, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171594, 1768171594, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139592, 6977, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171597, 1768171597, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139593, 6982, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768171599, 1768171599, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139594, 6983, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768171601, 1768171601, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139595, 6984, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', X'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', NULL, 'NCBI', 1768171603, 1768171603, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (139596, 6993, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'NCBI', 1768171606, 1768171606, NULL, NULL, NULL, NULL, NULL, NULL, NULL);